Abbott restarts Similac infant formula production at Sturgis plant after six-month shutdown
date:Aug 30, 2022
Abbott Nutrition is restarting infant formula production at its Sturgis plant, Michigan, US, after halting Similac production in February. The company estimates products will hit the shelves in six weeks after production restarts.

We know that the nationwide infant formula shortage has been difficult for the families we serve, and while restarting Similac production in Michigan is an important milestone, we wont rest until this product is back on shelves, says Robert B. Ford, chairman and CEO a
1/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/21 01:31